Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The main research goal of Jennifer Whitwell, Ph.D., is to use neuroimaging to increase understanding of how the brain changes in patients with a range of different neurodegenerative diseases, particularly frontotemporal dementia, progressive supranuclear palsy, apraxia of speech, primary progressive aphasia and atypical presentations of Alzheimer's disease. She utilizes magnetic resonance imaging (MRI) and positron emission tomography (PET) scans to assess structural and functional changes in the brain and determine how these changes are related to clinical symptoms and disease progression. Dr. Whitwell's research is funded by the National Institutes of Health and the Alzheimer's Association.
Neuroimaging biomarkers for neurodegenerative diseases will assist in early diagnosis and prediction of future progression and will be essential to the development of future treatments.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.